Skip to content

Intervention Study Investigating the Effect of a Phospholipid Drink on Cognitive Performance in 6-8 Year Old School Children

A Randomised, Double-blind, Parallel Groups, Placebo-controlled 6 Week Human Intervention Study Investigating the Effect of a Phospholipid Drink on Cognitive Performance in 6-8 Year Old School Children

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03705572
Enrollment
165
Registered
2018-10-15
Start date
2014-05-31
Completion date
2015-04-30
Last updated
2018-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Milk, Lacprodan PL20, Glycerophospholipids, Cognition

Brief summary

Six week RCT intervention on the effects of phospholipid containing milk drink vs. placebo milk drink on cognitive performance in 6-8 year old school children.

Detailed description

A randomised, double blind, placebo controlled study with parallel groups investigating a 6 week intervention in 6-8 year old school children of phospholipid containing milk drink vs. placebo milk drink. Participants were familiarised with the test battery and IQ (Wechsler abbreviated scale of intelligence) and colour blindness (Ishihara test) measurements were taken prior to the intervention. Milk drink taste testing and milk preference selection was also carried out prior to the intervention. The test battery was administered at baseline (week 0), midpoint (week 3) and endpoint (week 6), and the milk intervention was given Monday - Friday at school shortly before their mid-morning break over a 6 week period. This study design, including both the test days and morning milk supplementation, was intended to emulate the children's normal routine as far as possible. The milk drink was a supplement to the children's usual diet.

Interventions

DIETARY_SUPPLEMENTLacprodan PL20

Milk protein concentrate that is high in phospholipid content (min 16%).

OTHERPlacebo

Placebo milk drink.

Sponsors

Arla Foods
CollaboratorINDUSTRY
University of Leeds
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Years to 8 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or female, aged 6-8 years. * Willingness to consume milk drinks during the study determined by a score of \>5 on a taste testing Likert scale for at least one flavour of the milk drinks. * Ability to follow verbal and simple written instructions in English. * Normal vision, with appropriate corrective lenses if required. * Ability to understand cognitive testing instructions and responding requirements.

Exclusion criteria

* Poor general health. * Colour blindness. * Behavioural difficulties or attention disorders (e.g. Attention Deficit Hyperactivity Disorder). * Learning disabilities that interfere with the ability to understand written or verbal communications. * Inability to understand the objective of the cognitive tests, or carry out the tests. * Any food allergies or intolerances (e.g. lactose intolerance). * Acute illness, or feelings of unwell, within the week prior to testing. * Current administration of any psychotropic medication or supplementation in the month prior to testing, or during testing. * Hearing impairment that precludes the ability to follow verbal instructions. * Children already receiving milk at school unless parents are willing to substitute current milk with the study milk.

Design outcomes

Primary

MeasureTime frameDescription
Rivermead Behavioural Memory Test for Children (RBMT-C) change from baselineWeek 0, week 3 & week 6Test of immediate and delayed verbal memory recall.

Secondary

MeasureTime frameDescription
Motor Screening Task (CANTAB suite) change from baselineWeek 0, week 3 & week 6To identify motor impairment. Dependent variables: reaction time for each trial and distance from cross.
Spatial Recognition Memory (CANTAB suite) change from baselineWeek 0, week 3 & week 6Dependent variables: number of correct trials and reaction time for each trial.
Spatial Span (CANTAB suite) change from baselineWeek 0, week 3 & week 6Dependent variables: highest span reached, number of correct responses, number of incorrect responses and reaction time for each trial.
Reaction time (CANTAB suite) change from baselineWeek 0, week 3 & week 6Dependent variables: mental reaction time and movement time for each trial, number of correct responses, number of incorrect responses and number of invalid responses. Two parts to the task included simple, one response option, and choice, 5 response options.
Subjective mood questionnaire change from baselineWeek 0, week 3 & week 6Visual Analogue Scale.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026